Pharmaceuticals - Community Register


List of refusals for human medicinal products


Product name: Luveniq
Active substance: voclosporin
Indication: for the treatment of chronic non-infectious uveitis involving the intermediate or posterior segments of the eye.
Marketing Authorisation Holder: Lux Biosciences GmbH

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/01/2012 Centralised - Refusal of marketing authorisation EMEA/H/C/2069 (2012)410 of 20/01/2012